BVX-0320 (BioVaxys/Ohio State University)

N/A

Report date: 2025/06/11 10:17:35

Base Information

Drug NameBVX-0320 (BioVaxys/Ohio State University)
Drug Alias Namehaptenized SARS-CoV-2 spike glycoprotein subunit vaccine (BioVaxys/Ohio State University)
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionCoronavirus spike glycoprotein modulatorsT lymphocytes stimulants
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBioVaxys Inc
China Registration ClassN/A

Develop Information

Active CompaniesBioVaxys IncThe Ohio State University
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A